Part,  Chapter, Paragraph

 1   II,     5.  5.  2|           genetic vulnerability or abnormalities cannot be directly influenced.
 2   II,     5.  5.  3|          to these substances since abnormalities of glucose regulation were
 3   II,     5.  5.  3|         increased frequency of EEG abnormalities and seizure disorder.~·
 4   II,     5.  5.  3|         those with progressive CNS abnormalities such as brain tumours, genetic,
 5   II,     5.  7.  1|           structural or functional abnormalities of the kidneys persist for
 6   II,     5.  7.  1|           Structural or functional abnormalities of the kidneys for >3 months,
 7   II,     5.  7.  1|            defined by~• pathologic abnormalities~• markers of kidney damage~
 8   II,     5.  7.  1|           of kidney damage~urinary abnormalities (proteinuria)~blood abnormalities (
 9   II,     5.  7.  1|  abnormalities (proteinuria)~blood abnormalities (renal tubular syndromes)~
10   II,     5.  7.  1|         tubular syndromes)~imaging abnormalities~• kidney transplantation~
11   II,     5. 11.  3| Propionibacterium acnes) and other abnormalities of the skin which lead to
12   II,     8.  2.  1|     prevent certain kinds of brain abnormalities. Advances in the practices
13   II,     9        |         matures. Though congenital abnormalities are well recorded within
14   II,     9.  2.  4|         matures. Though congenital abnormalities are well recorded within
15  III,    10.  4.  2|  combination with~hepatitis) Liver~abnormalities, tumours~genotoxic carcinogen~ ~
16  III,    10.  4.  2|            altered development and abnormalities at birth. Although cloning
17   IV,    12. 10    |         chromosomal and structural abnormalities. It expands breast cancer